Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on Serological Profiles: Focus on Anti-Centromere and Anti-RNA Polymerase III Antibodies
Related Posts
Sakamoto H, Yamasaki L, Abe SK, Ezoe S, Egawa S, Guinto RR, Hashimoto H, Igarashi A, Lekagul A, Lwin KS, Mukaigawara M, Namkoong H, Nishino[...]
Pedamallu H, Khan SS, Haywood C, Baldridge AS, Grady KL, Chuzi S, Goyal P, Fonarow GC, Lagu T, Ahmad FS. Functional Limitations in Heart Failure[...]
Zhang K, Lampridis S, Simone CB 2nd, Negoi I, Peng Y, Shang B, Lin Y, Cheng Y, Yang F, Shelat VG, Kalantar-Zadeh K. A literature[...]